Drug Fix: What’s Next For US FDA After Senior Leadership Purge

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the impact of the US Food and Drug Administration’s purge of multiple center directors and other senior executives in the wake of Commissioner Martin Makary’s resignation (:34). They also discuss the agency’s potential new direction and the initial comments of some of its new leaders (15:12). More On These Topics From The Pink Sheet US FDA’s Real-Time Clinical Trial Pilot Seeks Expansion As Chief Architect Departs: Acting CDER Director Warns AI Over-Reliance Will Trigger GMP Violations: US FDA Chief AI Officer Departs, But Ousted Chief Of Staff, Acting CBER Director Staying: 13 Center Directors Across CDER, CBER In 17 Months … And Counting: Diamantas Extends Olive Branch To US FDA Staff Amid Senior Leader Shake-Up:

You can listen to Drug Fix: What’s Next For US FDA After Senior Leadership Purge online on Radio and Podcast. Open the player on this page to stream the available audio.

Drug Fix: What’s Next For US FDA After Senior Leadership Purge is an episode from Pharma Intelligence Podcasts.

This episode is 26:40 long.

This episode was published on May 22, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Pharma Intelligence Podcasts when more episodes are available from the podcast feed.